Limei Yin

1.4k total citations · 1 hit paper
19 papers, 508 citations indexed

About

Limei Yin is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Limei Yin has authored 19 papers receiving a total of 508 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 9 papers in Molecular Biology and 7 papers in Cancer Research. Recurrent topics in Limei Yin's work include Cancer, Hypoxia, and Metabolism (6 papers), Cancer Immunotherapy and Biomarkers (6 papers) and CAR-T cell therapy research (3 papers). Limei Yin is often cited by papers focused on Cancer, Hypoxia, and Metabolism (6 papers), Cancer Immunotherapy and Biomarkers (6 papers) and CAR-T cell therapy research (3 papers). Limei Yin collaborates with scholars based in China, Japan and United States. Limei Yin's co-authors include You Lü, Jianxin Xue, Ruizhan Tong, Yuncong Liu, Mengqian Li, Li Wu, Liting You, Hirohisa Kurachi, Keiko Takata and Kazuhiro Takahashi and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Limei Yin

16 papers receiving 506 citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Global, regional, and national burden of female cancers in women of child-bearing age, 1990–2021: analysis of data from the global burden of disease study 2021

2024 86 citations Ping Sun, Chang Yu et al. EClinicalMedicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Limei Yin China	11	243	143	129	67	64	19	508
Elizabeth K. Lee United States	13	309 1.3×	205 1.4×	120 0.9×	153 2.3×	59 0.9×	34	662
Tomokazu Umezu Japan	17	185 0.8×	198 1.4×	96 0.7×	68 1.0×	67 1.0×	32	592
Lesley Lomo United States	15	232 1.0×	206 1.4×	185 1.4×	82 1.2×	133 2.1×	27	707
Joanne Jeter United States	14	349 1.4×	154 1.1×	57 0.4×	106 1.6×	117 1.8×	37	675
Silverio Tomao Italy	13	253 1.0×	177 1.2×	84 0.7×	60 0.9×	76 1.2×	23	506
Xinxin Zhu China	13	387 1.6×	157 1.1×	242 1.9×	144 2.1×	111 1.7×	19	650
Valentina Tuninetti Italy	12	271 1.1×	186 1.3×	111 0.9×	100 1.5×	125 2.0×	28	600
Paweł Mach Germany	16	186 0.8×	127 0.9×	210 1.6×	81 1.2×	168 2.6×	59	646
Hui Tang China	12	242 1.0×	204 1.4×	104 0.8×	114 1.7×	111 1.7×	33	563
S. Garcia France	14	222 0.9×	165 1.2×	50 0.4×	81 1.2×	87 1.4×	46	551

Countries citing papers authored by Limei Yin

Since Specialization

Citations

This map shows the geographic impact of Limei Yin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Limei Yin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Limei Yin more than expected).

Fields of papers citing papers by Limei Yin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Limei Yin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Limei Yin. The network helps show where Limei Yin may publish in the future.

Co-authorship network of co-authors of Limei Yin

This figure shows the co-authorship network connecting the top 25 collaborators of Limei Yin. A scholar is included among the top collaborators of Limei Yin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Limei Yin. Limei Yin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Fan, Mingyu, et al.. (2025). Enhanced multi-omics analysis reveals a lncRNA signature with 12 RNA modifications to predict tumor heterogeneity and potential therapy in non-small cell lung cancer. Discover Oncology. 16(1). 1873–1873.

Li, Zifeng, Limei Yin, Shilei Zhao, et al.. (2025). Evolutionary divergence on the Qinghai–Xizang Plateau: How life-history traits shape the diversity of plateau zokor and pika populations. Journal of genetics and genomics. 52(9). 1096–1108.

Sun, Ping, Chang Yu, Limei Yin, et al.. (2024). Global, regional, and national burden of female cancers in women of child-bearing age, 1990–2021: analysis of data from the global burden of disease study 2021. EClinicalMedicine. 74. 102713–102713. 86 indexed citations breakdown →

Yin, Limei, Zhengwei Wan, Ping Sun, Ping Shuai, & Yuping Liu. (2023). Time to abandon CAR-T monotherapy for solid tumors. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1878(4). 188930–188930. 11 indexed citations

Chen, Xueqi, Shan-Yu Su, Yan Yan, Limei Yin, & Lihong Liu. (2023). Anti-Pseudomonas aeruginosa activity of natural antimicrobial peptides when used alone or in combination with antibiotics. Frontiers in Microbiology. 14. 1239540–1239540. 8 indexed citations

Li, Rui, Yuncong Liu, Rutie Yin, et al.. (2021). The Dynamic Alternation of Local and Systemic Tumor Immune Microenvironment During Concurrent Chemoradiotherapy of Cervical Cancer: A Prospective Clinical Trial. International Journal of Radiation Oncology*Biology*Physics. 110(5). 1432–1441. 28 indexed citations

Yin, Limei, Jianxin Xue, Lin Zhou, et al.. (2020). Effect Of Low-Dose Radiotherapy On Abscopal Responses To Hypofractionated Radiotherapy And Anti-PD1 In Mice and NSCLC Patients. International Journal of Radiation Oncology*Biology*Physics. 108(3). e563–e563. 3 indexed citations

Liu, Yuncong, Li Wu, Ruizhan Tong, et al.. (2019). PD-1/PD-L1 Inhibitors in Cervical Cancer. Frontiers in Pharmacology. 10. 65–65. 117 indexed citations

Yin, Limei, Xiaojuan Zhou, Ruizhan Tong, et al.. (2018). Assessment of programmed cell death ligand-1 expression with multiple immunohistochemistry antibody clones in non-small cell lung cancer. Journal of Thoracic Disease. 10(2). 816–824. 11 indexed citations

10.

Yin, Limei, et al.. (2018). Low-Dose Irradiation As Response Modifier to Maximize the Abscopal Effect and Synergize with Immunotherapy. International Journal of Radiation Oncology*Biology*Physics. 102(3). S202–S203.

11.

Sun, Xun, et al.. (2018). Synergy Between Peroxisome Proliferator-Activated Receptor γ Agonist and Radiation Therapy in Cancer. International Journal of Radiation Oncology*Biology*Physics. 102(3). S116–S117. 1 indexed citations

12.

Lan, Jie, Rui Li, Limei Yin, et al.. (2018). Targeting Myeloid-derived Suppressor Cells and Programmed Death Ligand 1 Confers Therapeutic Advantage of Ablative Hypofractionated Radiation Therapy Compared With Conventional Fractionated Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 101(1). 74–87. 84 indexed citations

13.

Yin, Limei, Jianxin Xue, Feifei Na, et al.. (2018). PDGFR-β inhibitor slows tumor growth but increases metastasis in combined radiotherapy and Endostar therapy. Biomedicine & Pharmacotherapy. 99. 615–621. 11 indexed citations

14.

Yin, Limei, Jie Lan, Ruizhan Tong, et al.. (2018). Synergy between peroxisome proliferator‐activated receptor γ agonist and radiotherapy in cancer. Cancer Science. 109(7). 2243–2255. 13 indexed citations

15.

Yin, Limei & You Lü. (2018). [MET Exon 14 Skipping Mutations in Non-small Cell Lung Cancer].. SHILAP Revista de lepidopterología. 21(7). 553–559. 2 indexed citations

16.

Sun, Xiaowen, et al.. (2018). PPARγ agonist to inhibit tumor progression by modulating tumor microenvironment.. Journal of Clinical Oncology. 36(15_suppl). e24012–e24012. 2 indexed citations

17.

Takahashi, Kazuhiro, Botao Du, Limei Yin, et al.. (2011). Estrogen induces neurite outgrowth via Rho family GTPases in neuroblastoma cells. Molecular and Cellular Neuroscience. 48(3). 217–224. 15 indexed citations

18.

Takata, Keiko, Ken‐ichirou Morishige, Toshifumi Takahashi, et al.. (2008). Fasudil-induced hypoxia-inducible factor-1α degradation disrupts a hypoxia-driven vascular endothelial growth factor autocrine mechanism in endothelial cells. Molecular Cancer Therapeutics. 7(6). 1551–1561. 41 indexed citations

19.

Yin, Limei, Ken‐ichirou Morishige, Toshifumi Takahashi, et al.. (2007). Fasudil inhibits vascular endothelial growth factor–induced angiogenesisin vitroandin vivo. Molecular Cancer Therapeutics. 6(5). 1517–1525. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact